JOHN JOHNSON - 19 Jun 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/S/ Marc Began, as attorney-in-fact for John Johnson
Issuer symbol
AXGN
Transactions as of
19 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 16:11:10 UTC
Previous filing
11 Jun 2025
Next filing
15 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JOHNSON JOHN Director C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400, ALACHUA /S/ Marc Began, as attorney-in-fact for John Johnson 20 Jun 2025 0001410781

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Award $0 +14,150 $0.000000 14,150 19 Jun 2025 Common Stock 14,150 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.